tiprankstipranks
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Income Statement

Compare
2 Followers

CStone Pharmaceuticals Income Statement

Last quarter (Q2 2024), CStone Pharmaceuticals's total revenue was ¥127.08M, a decrease of -2.80% from the same quarter last year. In Q2, CStone Pharmaceuticals's net income was ¥7.85M. See CStone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 463.84M¥ 481.36M¥ 243.72M¥ 1.04B¥ 0.00
Gross Profit
¥ 304.30M¥ 278.38M¥ 136.89M¥ 797.41M¥ 0.00
Operating Expenses
¥ 304.30M¥ 1.18B¥ 1.93B¥ 1.86B¥ 1.74B
Depreciation and Amortization
¥ 58.19M¥ 44.54M¥ 22.66M¥ 14.80M¥ 6.40M
EBITDA
¥ -297.23M¥ -849.66M¥ -1.90B¥ -1.20B¥ -1.73B
Operating Income
¥ -534.61M¥ -832.27M¥ -1.85B¥ -1.22B¥ -1.56B
Other Income/Expenses
¥ 167.37M¥ 9.47M¥ -90.66M¥ -129.07M¥ -571.34M
Pretax Income
¥ -367.23M¥ -902.68M¥ -1.92B¥ -1.22B¥ -2.31B
Net Income
¥ -367.23M¥ -964.61M¥ -1.99B¥ -1.22B¥ -3.06B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -0.29¥ -0.82¥ -1.71¥ -1.17¥ -3.53
Diluted EPS
¥ -0.29¥ -0.82¥ -1.71¥ -1.17¥ -3.53
Weighted Average Shares Outstanding
1.26B 1.17B 1.16B 1.04B 865.58M
Weighted Average Shares Outstanding (Diluted)
1.26B 1.17B 1.17B 1.05B 866.73M
Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis